Neolara Corp. Reports Leadership Changes in 8-K Filing
| Field | Detail |
|---|---|
| Company | Neolara Corp. |
| Form Type | 8-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, governance, 8-k
TL;DR
Neolara's leadership just got a shake-up, check the 8-K for details.
AI Summary
Neolara Corp. filed an 8-K on September 19, 2025, reporting changes in control and departures/appointments of officers and directors. The filing indicates a shift in the company's leadership structure and governance.
Why It Matters
Significant changes in a company's leadership can signal strategic shifts or potential instability, impacting investor confidence and future operations.
Risk Assessment
Risk Level: medium — Changes in control and executive departures can introduce uncertainty and potential strategic shifts, warranting closer investor scrutiny.
Key Players & Entities
- Neolara Corp. (company) — Registrant
- September 19, 2025 (date) — Date of Report
FAQ
What specific changes in control were reported by Neolara Corp.?
The filing indicates 'Changes in Control of Registrant' as an item reported, but the specific details of these changes are not elaborated in the provided text.
Who has departed from Neolara Corp.'s board or officer positions?
The filing lists 'Departure of Directors or Certain Officers' as an item, but the names of the individuals are not specified in the provided text.
Were there any new appointments to Neolara Corp.'s board or officer positions?
Yes, the filing mentions 'Election of Directors' and 'Appointment of Certain Officers' as reported items.
What is the primary business of Neolara Corp. according to the filing?
Neolara Corp. is classified under 'GEN BUILDING CONTRACTORS - RESIDENTIAL BUILDINGS [1520]' and is associated with '05 Real Estate & Construction'.
In which state is Neolara Corp. incorporated?
Neolara Corp. is incorporated in Wyoming (WY).
Filing Stats: 878 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2025-09-19 16:49:54
Filing Documents
- neolara_8k.htm (8-K) — 29KB
- 0001683168-25-007155.txt ( ) — 188KB
- none-20250919.xsd (EX-101.SCH) — 3KB
- none-20250919_lab.xml (EX-101.LAB) — 33KB
- none-20250919_pre.xml (EX-101.PRE) — 22KB
- neolara_8k_htm.xml (XML) — 3KB
01 Changes in Control
Item 5.01 Changes in Control of Registrant. Effective September 19, 2025, Julio Antonio Quesada Murillo, the previous Chief Executive Officer, director and majority shareholder of Neolara Corp. (the "Company"), entered into a stock purchase agreement for the sale of 2,000,000 shares of Common Stock of the Company, representing approximately 63% of the issued and outstanding shares of Common Stock of the Company as of such date, to Cao Wei, and as such Mr. Cao able to unilaterally control the election of our board of directors, all matters upon which shareholder approval is required and, ultimately, the direction of our Company. Also effective September 19 2025, Julio Antonio Quesada Murillo, Luis Diego Chavarria Arce and Carlos Alvarez Rojas resigned from all executive officer positions with the Company, including Chief Executive Officer and President, and as members of the Board, and effective the same day, Cao Wei was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.
02 Departure of Directors
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. The disclosures set forth in Item 5.01 above are incorporated by reference into this Item 5.02(a). The business background descriptions of the newly appointed officer and director is as follows: Cao Wei - President, Chief Executive Officer, Secretary, and Director From 2022 to 2024, Cao Wei served as Senior Architectural Designer of Wuhan Shangjian Construction Co., Ltd. From 2019 to 2022, he served as Senior Architect of Hubei Xinjie Construction Engineering Co., Ltd. From 2015 to 2018, he was Senior Architectural Design Manager of Hubei Fuhua Construction and Installation Co., Ltd. From 2014 to 2015, he served as Construction Project Manager of Jingzhou Junyu Construction Engineering Co., Ltd. Mr. Cao holds a Bachelor of Civil Engineering from Hubei University of Technology. Li Yan - Director Since 2021, Li Yan has served as Senior Biomedical Engineer at Hubei Bokang Medical Technology Co., Ltd., leading clinical validation of medical devices to meet regulatory requirements, optimizing flagship products to reduce failure rates, and mentoring junior engineers. From 2018 to 2021, he/she was Product Development Engineer at Wuhan Huakang Century Clean Technology Co., Ltd., where he/she enhanced system stability, authored technical documentation, and improved customer satisfaction. From 2016 to 2018, he/she was Technical Support Engineer at Jingzhou Yihai Technology Ltd., contributing to new product launches, clinical trials, and compliance testing. Li Yan received a Bachelor's degree in Biomedical Engineering from Hubei University of Science and Technology. Lloveras Amador Ricado - Director From 2021 to 2025, Mr. Lloveras served as Senior Software Developer of Softtek Digital Solutions SL, where he led Java and JavaScript web application development, established automated testing frameworks, and mentored junior developers. From 2019 to 2021,